Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands

EL Barker, HL Kimmel and RD Blakely

Department of Anatomy and Cell Biology, Emory University School of Medicine, Atlanta, Georgia 30322.

The serotonin transporter (SERT) is a target for many clinically significant drugs, such as cocaine, amphetamine, and antidepressants. The relationship between the structure of SERT and the binding of substrates and antagonists is virtually unknown, despite a large body of data describing the structure-activity relationships of transporter ligands. The cloning of multiple species homologs of SERT affords a unique opportunity for molecular comparisons to identify potential domains and residues involved in ligand recognition. We have conducted pharmacological comparisons of the cloned rat and human SERTs in transiently transfected HeLa cells. Serotonin uptake and radioligand binding assays revealed that rat and human SERTs show different sensitivities to some but not all transporter ligands; most tricyclic antidepressants were significantly more potent at the human SERT, relative to rat SERT, whereas d-amphetamine was a more potent inhibitor of rat SERT. Several other ligand such as fluoxetine, paroxetine, (+)- methylenedioxymethamphetamine, cocaine, and the substrate 5- hydroxytryptamine, shows no significant species selectivity. Cross- species chimeras between rat and human SERTs were constructed to track the species-specific pharmacologies through the SERT molecule. These chimeric SERTs were expressed in HeLa cells and transported serotonin similarly to parental SERTs. Using these chimeras, we have isolated a region distal to amino acid 532 the imparts species preferences for both the tricyclic imipramine and d-amphetamine. Our results support the prediction of distinct binding sites for SERT ligands and implicate a restricted region in or near putative transmembrane domain 12 of the transport as being involved in both substrate and antagonist recognition.

Volume 46, Issue 5, pp. 799-807, 11/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Dayem, C. Basquin, V. Navarro, P. Carrier, R. Marsault, P. Chang, S. Huc, E. Darrouzet, S. Lindenthal, and T. Pourcher Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization J. Endocrinol., April 1, 2008; 197(1): 95 - 109. [Abstract] [Full Text] [PDF]

				L. K. Henry, J. R. Field, E. M. Adkins, M. L. Parnas, R. A. Vaughan, M.-F. Zou, A. H. Newman, and R. D. Blakely Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants J. Biol. Chem., January 27, 2006; 281(4): 2012 - 2023. [Abstract] [Full Text] [PDF]

				M. K. Hahn, M. S. Mazei-Robison, and R. D. Blakely Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation Mol. Pharmacol., August 1, 2005; 68(2): 457 - 466. [Abstract] [Full Text] [PDF]

				C. Pifl, G. Nagy, S. Berenyi, A. Kattinger, H. Reither, and S. Antus Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 346 - 354. [Abstract] [Full Text] [PDF]

				M. B. Larsen, B. Elfving, and O. Wiborg The Chicken Serotonin Transporter Discriminates between Serotonin-selective Reuptake Inhibitors: A SPECIES-SCANNING MUTAGENESIS STUDY J. Biol. Chem., October 1, 2004; 279(40): 42147 - 42156. [Abstract] [Full Text] [PDF]

				G. J. Rodriguez, D. L. Roman, K. J. White, D. E. Nichols, and E. L. Barker Distinct Recognition of Substrates by the Human and Drosophila Serotonin Transporters J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 338 - 346. [Abstract] [Full Text] [PDF]

				M. Li and H. A. Lester Early Fluorescence Signals Detect Transitions at Mammalian Serotonin Transporters Biophys. J., July 1, 2002; 83(1): 206 - 218. [Abstract] [Full Text] [PDF]

				H. H. Sitte, B. Hiptmair, J. Zwach, C. Pifl, E. A. Singer, and P. Scholze Quantitative Analysis of Inward and Outward Transport Rates in Cells Stably Expressing the Cloned Human Serotonin Transporter: Inconsistencies with the Hypothesis of Facilitated Exchange Diffusion Mol. Pharmacol., April 16, 2001; 59(5): 1129 - 1137. [Abstract] [Full Text]

				E. M. Adkins, E. L. Barker, and R. D. Blakely Interactions of Tryptamine Derivatives with Serotonin Transporter Species Variants Implicate Transmembrane Domain I in Substrate Recognition Mol. Pharmacol., March 1, 2001; 59(3): 514 - 523. [Abstract] [Full Text]

				P. Pörzgen, S. K. Park, J. Hirsh, M. S. Sonders, and S. G. Amara The Antidepressant-Sensitive Dopamine Transporter in Drosophila melanogaster: A Primordial Carrier for Catecholamines Mol. Pharmacol., January 1, 2001; 59(1): 83 - 95. [Abstract] [Full Text]

				P. Scholze, J. Zwach, A. Kattinger, C. Pifl, E. A. Singer, and H. H. Sitte Transporter-Mediated Release: A Superfusion Study on Human Embryonic Kidney Cells Stably Expressing the Human Serotonin Transporter J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 870 - 878. [Abstract] [Full Text]

				S.-H. Lee, M.-y. Chang, K.-H. Lee, B. S. Park, Y.-S. Lee, H. R. Chin, and Y.-S. Lee Importance of Valine at Position 152 for the Substrate Transport and 2beta -Carbomethoxy-3beta -(4-fluorophenyl)tropane Binding of Dopamine Transporter Mol. Pharmacol., May 1, 2000; 57(5): 883 - 889. [Abstract] [Full Text]

				C. J. Loland, L. Norregaard, and U. Gether Defining Proximity Relationships in the Tertiary Structure of the Dopamine Transporter. IDENTIFICATION OF A CONSERVED GLUTAMIC ACID AS A THIRD COORDINATE IN THE ENDOGENOUS Zn2+-BINDING SITE J. Biol. Chem., December 24, 1999; 274(52): 36928 - 36934. [Abstract] [Full Text] [PDF]

				F. A. Paczkowski, L. J. Bryan-Lluka, P. Pörzgen, M. Brüss, and H. Bönisch Comparison of the Pharmacological Properties of Cloned Rat, Human, and Bovine Norepinephrine Transporters J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 761 - 767. [Abstract] [Full Text]

				E. L. Barker, K. R. Moore, F. Rakhshan, and R. D. Blakely Transmembrane Domain I Contributes to the Permeation Pathway for Serotonin and Ions in the Serotonin Transporter J. Neurosci., June 15, 1999; 19(12): 4705 - 4717. [Abstract] [Full Text] [PDF]

				A. J. Eshleman, M. Carmolli, M. Cumbay, C. R. Martens, K. A. Neve, and A. Janowsky Characteristics of Drug Interactions with Recombinant Biogenic Amine Transporters Expressed in the Same Cell Type J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 877 - 885. [Abstract] [Full Text]

				L. P. Shearman, A. M. McReynolds, F. C. Zhou, and J. S. Meyer Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1621 - C1629. [Abstract] [Full Text] [PDF]

				K. M. Y. Penado, G. Rudnick, and M. M. Stephan Critical Amino Acid Residues in Transmembrane Span 7 of the Serotonin Transporter Identified by Random Mutagenesis J. Biol. Chem., October 23, 1998; 273(43): 28098 - 28106. [Abstract] [Full Text] [PDF]

				Y. Cao, M. Li, S. Mager, and H. A. Lester Amino Acid Residues that Control pH Modulation of Transport-Associated Current in Mammalian Serotonin Transporters J. Neurosci., October 1, 1998; 18(19): 7739 - 7749. [Abstract] [Full Text] [PDF]

				J.-X. Chen, H. Pan, T. P. Rothman, P. R. Wade, and M. D. Gershon Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G433 - G448. [Abstract] [Full Text] [PDF]

				E. L. Barker, M. A. Perlman, E. M. Adkins, W. J. Houlihan, Z. B. Pristupa, H. B. Niznik, and R. D. Blakely High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis. AN AROMATIC RESIDUE IN TRANSMEMBRANE DOMAIN I DICTATES SPECIES-SELECTIVE RECOGNITION OF CITALOPRAM AND MAZINDOL J. Biol. Chem., July 31, 1998; 273(31): 19459 - 19468. [Abstract] [Full Text] [PDF]

				M. J. Owens, W. N. Morgan, S. J. Plott, and C. B. Nemeroff Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1305 - 1322. [Abstract] [Full Text]

				C. Sur, H. Betz, and P. Schloss A single serine residue controls the cation dependence of substrate transport by the rat serotonin transporter PNAS, July 8, 1997; 94(14): 7639 - 7644. [Abstract] [Full Text] [PDF]

				Y. Bismuth, M. P. Kavanaugh, and B. I. Kanner Tyrosine 140 of the gamma -Aminobutyric Acid Transporter GAT-1 Plays a Critical Role in Neurotransmitter Recognition J. Biol. Chem., June 27, 1997; 272(26): 16096 - 16102. [Abstract] [Full Text] [PDF]

				S. Apparsundaram, K. R. Moore, M. D. Malone, H. C. Hartzell, and R. D. Blakely Molecular Cloning and Characterization of an L-Epinephrine Transporter from Sympathetic Ganglia of the Bullfrog, Rana catesbiana J. Neurosci., April 15, 1997; 17(8): 2691 - 2702. [Abstract] [Full Text] [PDF]

				Y. Qian, A. Galli, S. Ramamoorthy, S. Risso, L. J. DeFelice, and R. D. Blakely Protein Kinase C Activation Regulates Human Serotonin Transporters in HEK-293 Cells via Altered Cell Surface Expression J. Neurosci., January 1, 1997; 17(1): 45 - 57. [Abstract] [Full Text] [PDF]

				F. J.S. Lee, Z. B. Pristupa, B. J. Ciliax, A. I. Levey, and H. B. Niznik The Dopamine Transporter Carboxyl-terminal Tail. TRUNCATION/SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND BINDING DOMAIN J. Biol. Chem., August 23, 1996; 271(34): 20885 - 20894. [Abstract] [Full Text] [PDF]

				D. Peter, T. Vu, and R. H. Edwards Chimeric Vesicular Monoamine Transporters Identify Structural Domains That Influence Substrate Affinity and Sensitivity to Tetrabenazine J. Biol. Chem., February 9, 1996; 271(6): 2979 - 2986. [Abstract] [Full Text] [PDF]

				A. Merickel, P. Rosandich, D. Peter, and R. H. Edwards Identification of Residues Involved in Substrate Recognition by a Vesicular Monoamine Transporter J. Biol. Chem., October 27, 1995; 270(43): 25798 - 25804. [Abstract] [Full Text] [PDF]

				S. G. Amara Monoamine Transporters: Basic Biology with Clinical Implications Neuroscientist, September 1, 1995; 1(5): 259 - 267. [Abstract] [PDF]

				C. Roubert, P. J. Cox, M. Bruss, M. Hamon, H. Bonisch, and B. Giros Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity J. Biol. Chem., March 9, 2001; 276(11): 8254 - 8260. [Abstract] [Full Text] [PDF]